Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyruvic Acid | 3 | 2022 | 35 | 1.720 |
Why?
|
| Spin Labels | 1 | 2024 | 39 | 0.910 |
Why?
|
| Peroxidase | 1 | 2023 | 61 | 0.850 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2025 | 3526 | 0.830 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2025 | 224 | 0.790 |
Why?
|
| Echo-Planar Imaging | 1 | 2020 | 20 | 0.720 |
Why?
|
| Oxygen | 1 | 2024 | 539 | 0.700 |
Why?
|
| Gout | 1 | 2023 | 145 | 0.690 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 288 | 0.660 |
Why?
|
| Neoadjuvant Therapy | 4 | 2025 | 321 | 0.650 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 1515 | 0.560 |
Why?
|
| Phantoms, Imaging | 3 | 2022 | 127 | 0.410 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 534 | 0.370 |
Why?
|
| Bone Neoplasms | 3 | 2023 | 427 | 0.320 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 2486 | 0.250 |
Why?
|
| Osteogenesis | 2 | 2023 | 153 | 0.240 |
Why?
|
| Carbon Tetrachloride | 1 | 2024 | 7 | 0.230 |
Why?
|
| Myeloid Cells | 1 | 2024 | 98 | 0.230 |
Why?
|
| Immune Tolerance | 1 | 2024 | 144 | 0.220 |
Why?
|
| Lactates | 1 | 2022 | 89 | 0.210 |
Why?
|
| Ecosystem | 1 | 2023 | 76 | 0.210 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 239 | 0.200 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 518 | 0.190 |
Why?
|
| Carbon Isotopes | 1 | 2020 | 271 | 0.170 |
Why?
|
| Artifacts | 1 | 2020 | 103 | 0.170 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 69 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 261 | 0.170 |
Why?
|
| Bone and Bones | 1 | 2021 | 262 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 649 | 0.160 |
Why?
|
| Animals | 6 | 2024 | 33723 | 0.150 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 789 | 0.140 |
Why?
|
| Rats | 1 | 2024 | 3631 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 822 | 0.140 |
Why?
|
| Kidney | 1 | 2024 | 1338 | 0.140 |
Why?
|
| Mice | 5 | 2024 | 17487 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 2043 | 0.120 |
Why?
|
| Myelopoiesis | 2 | 2024 | 13 | 0.110 |
Why?
|
| Algorithms | 1 | 2020 | 1595 | 0.110 |
Why?
|
| ROC Curve | 2 | 2024 | 557 | 0.100 |
Why?
|
| Cell Communication | 2 | 2024 | 165 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2025 | 15998 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1580 | 0.090 |
Why?
|
| Humans | 11 | 2025 | 123157 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2766 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 2848 | 0.060 |
Why?
|
| Female | 7 | 2025 | 65444 | 0.060 |
Why?
|
| Middle Aged | 4 | 2025 | 25966 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2025 | 12116 | 0.060 |
Why?
|
| Anisotropy | 1 | 2024 | 122 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 353 | 0.060 |
Why?
|
| High-Temperature Requirement A Serine Peptidase 1 | 1 | 2023 | 5 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 11 | 0.050 |
Why?
|
| Bone Remodeling | 1 | 2023 | 54 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 6028 | 0.050 |
Why?
|
| Breast | 1 | 2024 | 214 | 0.050 |
Why?
|
| Aged | 3 | 2025 | 19067 | 0.050 |
Why?
|
| Male | 3 | 2022 | 60040 | 0.050 |
Why?
|
| Neutrophils | 1 | 2024 | 372 | 0.050 |
Why?
|
| Cadherins | 1 | 2023 | 164 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2021 | 38 | 0.050 |
Why?
|
| Clonal Evolution | 1 | 2021 | 38 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 57 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 222 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 285 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 17 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 1089 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 384 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 140 | 0.040 |
Why?
|
| Cell Count | 1 | 2020 | 247 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 571 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 312 | 0.040 |
Why?
|
| Adult | 3 | 2025 | 29034 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 394 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 692 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1062 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2023 | 533 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 696 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 876 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 322 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 637 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1115 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1677 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1907 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2023 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1780 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1680 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2307 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1870 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 1432 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4346 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4269 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4495 | 0.020 |
Why?
|